Meshinchi, Soheil and Appelbaum, Frederick R. (2009) Structural and functional Alterations of FLT3 in Acute Myeloid Leukemia. Clinical Cancer Research, 15 (13). pp. 4263-4269. ISSN 1078-0432
Preview |
Text (Manuscript)
MeshinchiSoheilCCRManuscript61009.pdf Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (243kB) | Preview |
Abstract
Hematopoiesis is highly regulated through cytokine-induced stimulation of multiple signal transduction pathways in order to mediate appropriate differentiation and proliferation of specific progenitor populations. Ligand-induced stimulation of the FMS-like tyrosine kinase 3 (FLT3) leads to activation of multiple downstream effector pathways resulting in differentiation and proliferation of specific progenitor cell populations. Genomic alterations of the FLT3 gene leads to autonomous receptor activation, dysregulation of FLT3 signal transduction pathways, contributes to myeloid pathogenesis, and have been linked to response to therapy and clinical outcome. Exploring the mechanisms by which these FLT3 alterations lead to dysregulated proliferation would provide a better understanding of the molecular pathogenesis of AML and may provide insights into potential therapeutic interventions.
Item Type: | Article or Abstract |
---|---|
Additional Information: | This article is available to subscribers only via the URL above. |
DOI: | 10.1158/1078-0432.CCR-08-1123 |
PubMed ID: | 19549778 |
NIHMSID: | NIHMS123594 |
PMCID: | PMC2716016 |
Grant Numbers: | CA114563 |
Keywords or MeSH Headings: | * Gene Duplication * Hematopoiesis/genetics * Humans * Leukemia, Myeloid, Acute/diagnosis * Leukemia, Myeloid, Acute/genetics* * Leukemia, Myeloid, Acute/therapy * Models, Biological * Mutation/physiology* * Prognosis * Protein Structure, Tertiary/genetics * Protein Structure, Tertiary/physiology * Structure-Activity Relationship * fms-Like Tyrosine Kinase 3/chemistry * fms-Like Tyrosine Kinase 3/genetics* * fms-Like Tyrosine Kinase 3/physiology* |
Subjects: | Cellular and Organismal Processes > Genetic processes > Mutation Diseases > Hematologic and lymphatic diseases > Leukemia Therapeutics > Drug Therapy |
Depositing User: | Library Staff |
Date Deposited: | 02 Sep 2009 16:22 |
Last Modified: | 14 Feb 2012 14:42 |
URI: | http://authors.fhcrc.org/id/eprint/297 |
Repository Administrators Only
View Item |